The text starts here.

News Release

FOR IMMEDIATE RELEASE
November 5, 2001

CHOCOLA BB(R) ROYAL, A 50 ml BOTTLE VITAMIN B2 DRINK
LAUNCHED BY EISAI

Tokyo (November 5, 2001) - Eisai Co., Ltd. of Tokyo (President and CEO: Haruo Naito) announced the launch of CHOCOLA BBR Royal on November 5th.


CHOCOLA BBR Royal is a liquid drink containing vitamin B2 vitamin B complex, and 1000 mg aminoethane sulfonic acid which are essential for creating energy and in promoting fat metabolism. CHOCOLA BBR Royal also contains royal jelly which is beneficial in times of physical fatigue, and a nutritive herbal extract in a 50 ml bottle.


CHOCOLA BBR Royal is a good nutritional supplement in times of physical exhaustion due to overwork and strenuous sports activities, and in times of fever and chills due to colds and flu. The drink has an easy to consume white grape flavor and each 50 ml bottle contains only 22.9 calories.


After regulatory changes involving drug distribution in 1999, Eisai introduced CHOCOLA BBR Fresh in April of 2000. And in July 2001, Eisai introduced CHOCOLA BBR Light.


Products in the CHOCOLA BBR Brand family have been designed to meet the varied needs of consumers. A homepage (in Japanese) with additional information on all CHOCOLA BBR brand family of products has been established. The address of this homepage is: http://www.chocola.com/


CHOCOLA BB Royal

For additional information about CHOCOLA BBR Royal and Eisai's other consumer health care products, please contact Eisai's Consumer Hotline.

Toll Free Number (in Japan): 0120-161-454.
Monday-Friday 9 a.m. - 6 p.m.
Saturday/ Sunday/ Holiday 9 a.m. - 5 p.m.


Eisai Co., Ltd. is a research-based human health care company which discovers, develops and markets products in more than 30 countries. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system. The company reported sales of over $2.9 billion in 2000 with approximately 14 percent of sales spent for research and development.